Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.

Journal of hepatology - 1 Oct 1997

Shiota G, Kishimoto Y, Suyama A, Okubo M, Katayama S, Harada K, Ishida M, Hori K, Suou T, Kawasaki H

Abstract excerpt

BACKGROUND/AIMS: Abnormalities of the p53 gene can lead to the production of anti-p53 antibody in the serum of cancer patients. We evaluated the prognostic significance of anti-p53 antibody in 86 patients with hepatocellular carcinoma (HCC) in comparison with clinicopathological factors: age, sex, etiology, smoking and drinking habits, history of blood transfusion, presence of encephalopathy and ascites, Child...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Mutation

Share to Neoplasm Proteins

Share to Prognosis

Share to Risk Factors

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9365042
DOI: 10.1016/s0168-8278(97)80083-9

Genes

AFP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.PMID 9365042Read ↗

Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma.Semantic proximity Read ↗

Prognostic significance of serum p53 antibody according to KRAS status in metastatic colorectal cancer patients.Semantic proximity Read ↗

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.Semantic proximity Read ↗

Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.Semantic proximity Read ↗

Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma.Semantic proximity Read ↗

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?Semantic proximity Read ↗

[Clinical importance of serum anti-p53 antibodies as tumor markers].Semantic proximity Read ↗

Prevalence and clinical relevance of serum anti-p53 antibodies in patients with cholangiocarcinoma.Semantic proximity Read ↗

Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?Semantic proximity Read ↗

The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.Semantic proximity Read ↗

Serum anti-p53 antibodies in uterine and ovarian cancer: association with dna sequence copy number abnormalities.Semantic proximity Read ↗

P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.